Skip to content
10-Q

Quarterly Report

AMEXDRUG CORP

0001096906-11-001842

← back to feed
Filed
Aug 12, 2011 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 8, 2011 8.46M sh
Shares Diluted Q2 2011 · Jun 30, 2011 8.47M sh
Shares Diluted Q2 2011 · Jun 30, 2011 8.47M sh
Shares Diluted Q2 2011 · Jun 30, 2010 8.47M sh
Shares Diluted Q2 2011 · Jun 30, 2010 8.47M sh
Stock Repurchased Q2 2011 · Jun 30, 2011 $1.1K
Stock Repurchased Q2 2011 · Jun 30, 2010 $1.44K
Capex Q2 2011 · Jun 30, 2011 $11.29K
Capex Q2 2011 · Jun 30, 2010 $2.45K
Operating Cash Flow Q2 2011 · Jun 30, 2011 −$246.05K
Operating Cash Flow Q2 2011 · Jun 30, 2010 −$22.83K
Cash And Equivalents Q2 2011 · Jun 30, 2011 $151.16K
Cash And Equivalents Q2 2011 · Mar 31, 2011 $443.7K
Cash And Equivalents Q2 2011 · Dec 31, 2010 $443.7K
Cash And Equivalents Q2 2011 · Jun 30, 2010 $135.02K
Cash And Equivalents Q2 2011 · Mar 31, 2010 $121.18K
Stockholders Equity Q2 2011 · Jun 30, 2011 $485.02K
Stockholders Equity Q2 2011 · Dec 31, 2010 $250.51K
Current Liabilities Q2 2011 · Jun 30, 2011 $1.04M
Current Liabilities Q2 2011 · Dec 31, 2010 $1.09M
Current Assets Q2 2011 · Jun 30, 2011 $1.45M
Current Assets Q2 2011 · Dec 31, 2010 $1.29M
Total Assets Q2 2011 · Jun 30, 2011 $1.52M
Total Assets Q2 2011 · Dec 31, 2010 $1.34M
Sga Expense Q2 2011 · Jun 30, 2010 $143.83K
Sga Expense Q2 2011 · Jun 30, 2010 $272.51K
Net Income Q2 2011 · Jun 30, 2010 $148.54K
Net Income Q2 2011 · Jun 30, 2010 $148.54K
Operating Income Q2 2011 · Jun 30, 2010 $122.83K
Operating Income Q2 2011 · Jun 30, 2010 $227.54K
Gross Profit Q2 2011 · Jun 30, 2010 $270.27K
Gross Profit Q2 2011 · Jun 30, 2010 $505.26K
Cost Of Revenue Q2 2011 · Jun 30, 2010 $2.67M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $5.18M
Revenue Q2 2011 · Jun 30, 2010 $2.94M
Revenue Q2 2011 · Jun 30, 2010 $5.69M